Karén Matevosyan

681 total citations
20 papers, 459 citations indexed

About

Karén Matevosyan is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Karén Matevosyan has authored 20 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Genetics and 6 papers in Immunology. Recurrent topics in Karén Matevosyan's work include Complement system in diseases (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Blood groups and transfusion (4 papers). Karén Matevosyan is often cited by papers focused on Complement system in diseases (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Blood groups and transfusion (4 papers). Karén Matevosyan collaborates with scholars based in United States and Canada. Karén Matevosyan's co-authors include Ravi Sarode, Cynthia Rutherford, James Burner, Yu‐Min Shen, Majed A. Refaai, Christopher J. Madden, Joseph E. Beshay, Lauren Phillips, Zora R. Rogers and Donna Graves and has published in prestigious journals such as Blood, Journal of neurosurgery and British Journal of Haematology.

In The Last Decade

Karén Matevosyan

18 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karén Matevosyan United States 13 176 126 105 92 90 20 459
Inga Hegemann Switzerland 13 241 1.4× 26 0.2× 32 0.3× 65 0.7× 78 0.9× 26 510
Emmanuelle Jeanpierre France 12 106 0.6× 40 0.3× 31 0.3× 66 0.7× 29 0.3× 33 408
Christophe Nougier France 11 195 1.1× 42 0.3× 88 0.8× 63 0.7× 49 0.5× 44 560
Jorge Labrador Spain 11 168 1.0× 58 0.5× 26 0.2× 42 0.5× 52 0.6× 32 380
Aliza Zeidman Israel 11 165 0.9× 66 0.5× 9 0.1× 74 0.8× 86 1.0× 33 372
Mehraboon S. Irani United States 11 172 1.0× 36 0.3× 11 0.1× 187 2.0× 29 0.3× 24 327
Constance F.M. Danielson United States 10 237 1.3× 118 0.9× 11 0.1× 37 0.4× 142 1.6× 19 387
C. Belizna France 10 100 0.6× 118 0.9× 99 0.9× 37 0.4× 43 0.5× 26 470
William B. Scharfman United States 13 220 1.3× 23 0.2× 30 0.3× 197 2.1× 53 0.6× 23 462
Wendy Lau Canada 14 148 0.8× 42 0.3× 14 0.1× 84 0.9× 32 0.4× 38 466

Countries citing papers authored by Karén Matevosyan

Since Specialization
Citations

This map shows the geographic impact of Karén Matevosyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karén Matevosyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karén Matevosyan more than expected).

Fields of papers citing papers by Karén Matevosyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karén Matevosyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karén Matevosyan. The network helps show where Karén Matevosyan may publish in the future.

Co-authorship network of co-authors of Karén Matevosyan

This figure shows the co-authorship network connecting the top 25 collaborators of Karén Matevosyan. A scholar is included among the top collaborators of Karén Matevosyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karén Matevosyan. Karén Matevosyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burner, James, et al.. (2017). Plasma exchange for the management of refractory pruritus of cholestasis: A report of three cases and review of literature. Journal of Clinical Apheresis. 33(3). 412–418. 9 indexed citations
2.
Brown, Timothy J., Suntrea T.G. Hammer, Christine Hwang, et al.. (2017). Novel Application of Extracorporeal Photopheresis as Treatment of Graft-versus-Host Disease Following Liver Transplantation. ACG Case Reports Journal. 4(1). e48–e48. 4 indexed citations
3.
Kim, Jaehyup, et al.. (2016). Comparison of Spectra Optia and COBE Spectra apheresis systems' performances for red blood cell exchange procedures. Transfusion and Apheresis Science. 55(3). 368–370. 15 indexed citations
4.
DeSena, Allen D., Karén Matevosyan, Kathryn King, et al.. (2015). Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti‐n‐methyl‐d‐aspartate receptor antibody encephalitis: A retrospective review. Journal of Clinical Apheresis. 30(4). 212–216. 63 indexed citations
5.
Matevosyan, Karén & Ravi Sarode. (2015). Thrombosis, Microangiopathies, and Inflammation. Seminars in Thrombosis and Hemostasis. 41(6). 556–562. 22 indexed citations
6.
Yates, Sean G., Karén Matevosyan, Cynthia Rutherford, Yu‐Min Shen, & Ravi Sarode. (2014). Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report. Transfusion. 54(8). 2064–2067. 31 indexed citations
7.
Rutherford, Cynthia, et al.. (2013). Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). British Journal of Haematology. 163(4). 514–519. 45 indexed citations
8.
Matevosyan, Karén, et al.. (2013). Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: A report of three cases. Journal of Clinical Apheresis. 29(2). 127–131. 18 indexed citations
9.
Sarode, Ravi, Karén Matevosyan, Zora R. Rogers, James Burner, & Cynthia Rutherford. (2011). Advantages of isovolemic hemodilution‐red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients. Journal of Clinical Apheresis. 26(4). 200–207. 42 indexed citations
10.
Sarode, Ravi, et al.. (2011). Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage. Journal of neurosurgery. 116(3). 491–497. 60 indexed citations
11.
Matevosyan, Karén, et al.. (2010). Rinseback during red blood cell exchange with COBE Spectra does not affect fraction of cells remaining or post‐exchange hematocrit. Journal of Clinical Apheresis. 25(6). 347–349. 2 indexed citations
12.
Matevosyan, Karén, Christopher J. Madden, Samuel Barnett, et al.. (2010). Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: effect on plasma transfusion therapy. Journal of neurosurgery. 114(1). 3–7. 17 indexed citations
13.
Patel, Prapti A., Catherine Burke, Karén Matevosyan, et al.. (2009). Low Risk 4T Score Can Rule out Heparin-Induced Thrombocytopenia.. Blood. 114(22). 1328–1328.
14.
Park, Yara A., Shauna N. Hay, Karen E. King, et al.. (2009). Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy. Journal of Clinical Apheresis. 24(3). 115–119. 17 indexed citations
15.
Burke, Catherine, et al.. (2009). Optical Density of 1.0 Is a Better Cutoff for Positive HIT Ab ELISA.. Blood. 114(22). 3515–3515. 1 indexed citations
16.
Sarode, Ravi, et al.. (2009). Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. Transfusion. 50(2). 487–492. 48 indexed citations
17.
Altuntaş, Fevzi, Karén Matevosyan, James Burner, Yu‐Min Shen, & Ravi Sarode. (2008). Higher optical density of an antigen assay predicts thrombosis in patients with heparin‐induced thrombocytopenia. European Journal Of Haematology. 80(5). 429–435. 30 indexed citations
18.
Refaai, Majed A., Theodore E. Warkentin, Michael D. Axelson, Karén Matevosyan, & Ravi Sarode. (2007). Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: A consequence of heparin “flushes”. Thrombosis and Haemostasis. 98(11). 1139–1140. 31 indexed citations
19.
20.
Matevosyan, Karén, et al.. (1985). Characteristics of cellular and humoral immune responses after immunization with different rabies vaccines.. PubMed. 29(2). 137–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inga Hegemann Breakdown of academic impact, for papers by Emmanuelle Jeanpierre Breakdown of academic impact, for papers by Christophe Nougier Breakdown of academic impact, for papers by Jorge Labrador Breakdown of academic impact, for papers by Aliza Zeidman Breakdown of academic impact, for papers by Mehraboon S. Irani Breakdown of academic impact, for papers by Constance F.M. Danielson Breakdown of academic impact, for papers by C. Belizna Breakdown of academic impact, for papers by William B. Scharfman Breakdown of academic impact, for papers by Wendy Lau
Rankless by CCL
2026